Changes in the use of anti-asthmatic medication in an international cohort

Christer Janson, R. de Marco, S. Accordini, E. Almar, M. Bugiani, A. Carolei, L. Cazzoletti, I. Cerveri, A. Corsico, E. Duran-Tauleria, D. Gislason, A. Gulsvik, R. Jõgi, A. Marinoni, J. Martínez-Moratalla, I. Pin, P. Vermeire, D. Jarvis

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The aim of this study was to describe changes in pharmacotherapy for asthma since the early 1990s in an international cohort of young and middle-aged adults. A total of 28 centres from 14 countries participated in a longitudinal study. The study included 8,829 subjects with a mean follow-up time of 8.7 yrs. Change in the prevalence of use for medication was expressed as absolute net change (95% confidence interval) standardised to a 10-yr period. The use of anti-asthmatics was found to have increased by 3.1% (2.4-3.7%) and the prevalence of symptomatic asthma by 4.0% (3.5-4.5%). In the sample with asthma in both surveys (n=423), the use of inhaled corticosteroids increased by 12.2% (6.6-17.8%). Despite this, only 17.2% were using inhaled corticosteroids on a daily basis at follow-up. Females with continuous asthma were more likely, compared with males, and smokers with asthma, to have started using inhaled corticosterolds since the first survey. The use of anti-asthmatics has increased in a pattern consistent with current consensus on treatment. However, despite increased use of inhaled corticosterolds, a large majority of subjects with symptomatic asthma do not use this treatment on a daily basis, particularly males and smokers with asthma. Copyright

Original languageEnglish
Pages (from-to)1047-1055
Number of pages9
JournalEuropean Respiratory Journal
Volume26
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Anti-Asthmatic Agents
Asthma
Adrenal Cortex Hormones
Longitudinal Studies
Confidence Intervals
Drug Therapy
Therapeutics

Keywords

  • Asthma
  • Epidemiology
  • Inhaled corticosteroids
  • Smoking
  • Therapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Janson, C., de Marco, R., Accordini, S., Almar, E., Bugiani, M., Carolei, A., ... Jarvis, D. (2005). Changes in the use of anti-asthmatic medication in an international cohort. European Respiratory Journal, 26(6), 1047-1055. https://doi.org/10.1183/09031936.05.00031905

Changes in the use of anti-asthmatic medication in an international cohort. / Janson, Christer; de Marco, R.; Accordini, S.; Almar, E.; Bugiani, M.; Carolei, A.; Cazzoletti, L.; Cerveri, I.; Corsico, A.; Duran-Tauleria, E.; Gislason, D.; Gulsvik, A.; Jõgi, R.; Marinoni, A.; Martínez-Moratalla, J.; Pin, I.; Vermeire, P.; Jarvis, D.

In: European Respiratory Journal, Vol. 26, No. 6, 12.2005, p. 1047-1055.

Research output: Contribution to journalArticle

Janson, C, de Marco, R, Accordini, S, Almar, E, Bugiani, M, Carolei, A, Cazzoletti, L, Cerveri, I, Corsico, A, Duran-Tauleria, E, Gislason, D, Gulsvik, A, Jõgi, R, Marinoni, A, Martínez-Moratalla, J, Pin, I, Vermeire, P & Jarvis, D 2005, 'Changes in the use of anti-asthmatic medication in an international cohort', European Respiratory Journal, vol. 26, no. 6, pp. 1047-1055. https://doi.org/10.1183/09031936.05.00031905
Janson C, de Marco R, Accordini S, Almar E, Bugiani M, Carolei A et al. Changes in the use of anti-asthmatic medication in an international cohort. European Respiratory Journal. 2005 Dec;26(6):1047-1055. https://doi.org/10.1183/09031936.05.00031905
Janson, Christer ; de Marco, R. ; Accordini, S. ; Almar, E. ; Bugiani, M. ; Carolei, A. ; Cazzoletti, L. ; Cerveri, I. ; Corsico, A. ; Duran-Tauleria, E. ; Gislason, D. ; Gulsvik, A. ; Jõgi, R. ; Marinoni, A. ; Martínez-Moratalla, J. ; Pin, I. ; Vermeire, P. ; Jarvis, D. / Changes in the use of anti-asthmatic medication in an international cohort. In: European Respiratory Journal. 2005 ; Vol. 26, No. 6. pp. 1047-1055.
@article{84f9af2cb6fb45ef9574b2942e72fb7c,
title = "Changes in the use of anti-asthmatic medication in an international cohort",
abstract = "The aim of this study was to describe changes in pharmacotherapy for asthma since the early 1990s in an international cohort of young and middle-aged adults. A total of 28 centres from 14 countries participated in a longitudinal study. The study included 8,829 subjects with a mean follow-up time of 8.7 yrs. Change in the prevalence of use for medication was expressed as absolute net change (95{\%} confidence interval) standardised to a 10-yr period. The use of anti-asthmatics was found to have increased by 3.1{\%} (2.4-3.7{\%}) and the prevalence of symptomatic asthma by 4.0{\%} (3.5-4.5{\%}). In the sample with asthma in both surveys (n=423), the use of inhaled corticosteroids increased by 12.2{\%} (6.6-17.8{\%}). Despite this, only 17.2{\%} were using inhaled corticosteroids on a daily basis at follow-up. Females with continuous asthma were more likely, compared with males, and smokers with asthma, to have started using inhaled corticosterolds since the first survey. The use of anti-asthmatics has increased in a pattern consistent with current consensus on treatment. However, despite increased use of inhaled corticosterolds, a large majority of subjects with symptomatic asthma do not use this treatment on a daily basis, particularly males and smokers with asthma. Copyright",
keywords = "Asthma, Epidemiology, Inhaled corticosteroids, Smoking, Therapy",
author = "Christer Janson and {de Marco}, R. and S. Accordini and E. Almar and M. Bugiani and A. Carolei and L. Cazzoletti and I. Cerveri and A. Corsico and E. Duran-Tauleria and D. Gislason and A. Gulsvik and R. J{\~o}gi and A. Marinoni and J. Mart{\'i}nez-Moratalla and I. Pin and P. Vermeire and D. Jarvis",
year = "2005",
month = "12",
doi = "10.1183/09031936.05.00031905",
language = "English",
volume = "26",
pages = "1047--1055",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Changes in the use of anti-asthmatic medication in an international cohort

AU - Janson, Christer

AU - de Marco, R.

AU - Accordini, S.

AU - Almar, E.

AU - Bugiani, M.

AU - Carolei, A.

AU - Cazzoletti, L.

AU - Cerveri, I.

AU - Corsico, A.

AU - Duran-Tauleria, E.

AU - Gislason, D.

AU - Gulsvik, A.

AU - Jõgi, R.

AU - Marinoni, A.

AU - Martínez-Moratalla, J.

AU - Pin, I.

AU - Vermeire, P.

AU - Jarvis, D.

PY - 2005/12

Y1 - 2005/12

N2 - The aim of this study was to describe changes in pharmacotherapy for asthma since the early 1990s in an international cohort of young and middle-aged adults. A total of 28 centres from 14 countries participated in a longitudinal study. The study included 8,829 subjects with a mean follow-up time of 8.7 yrs. Change in the prevalence of use for medication was expressed as absolute net change (95% confidence interval) standardised to a 10-yr period. The use of anti-asthmatics was found to have increased by 3.1% (2.4-3.7%) and the prevalence of symptomatic asthma by 4.0% (3.5-4.5%). In the sample with asthma in both surveys (n=423), the use of inhaled corticosteroids increased by 12.2% (6.6-17.8%). Despite this, only 17.2% were using inhaled corticosteroids on a daily basis at follow-up. Females with continuous asthma were more likely, compared with males, and smokers with asthma, to have started using inhaled corticosterolds since the first survey. The use of anti-asthmatics has increased in a pattern consistent with current consensus on treatment. However, despite increased use of inhaled corticosterolds, a large majority of subjects with symptomatic asthma do not use this treatment on a daily basis, particularly males and smokers with asthma. Copyright

AB - The aim of this study was to describe changes in pharmacotherapy for asthma since the early 1990s in an international cohort of young and middle-aged adults. A total of 28 centres from 14 countries participated in a longitudinal study. The study included 8,829 subjects with a mean follow-up time of 8.7 yrs. Change in the prevalence of use for medication was expressed as absolute net change (95% confidence interval) standardised to a 10-yr period. The use of anti-asthmatics was found to have increased by 3.1% (2.4-3.7%) and the prevalence of symptomatic asthma by 4.0% (3.5-4.5%). In the sample with asthma in both surveys (n=423), the use of inhaled corticosteroids increased by 12.2% (6.6-17.8%). Despite this, only 17.2% were using inhaled corticosteroids on a daily basis at follow-up. Females with continuous asthma were more likely, compared with males, and smokers with asthma, to have started using inhaled corticosterolds since the first survey. The use of anti-asthmatics has increased in a pattern consistent with current consensus on treatment. However, despite increased use of inhaled corticosterolds, a large majority of subjects with symptomatic asthma do not use this treatment on a daily basis, particularly males and smokers with asthma. Copyright

KW - Asthma

KW - Epidemiology

KW - Inhaled corticosteroids

KW - Smoking

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=29244471723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244471723&partnerID=8YFLogxK

U2 - 10.1183/09031936.05.00031905

DO - 10.1183/09031936.05.00031905

M3 - Article

VL - 26

SP - 1047

EP - 1055

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 6

ER -